PTH and Marchiafava-Bignami disease: Association of CKD-MBD biomarkers and changes in 3D DXA parameters at the total hip regions from baseline over up to a maximum of 2.5 years based on multilevel mixed model analysis adjusting for sex, age, duration of dialysis, cause of ESKD, serum cCa levels, serum phosphate levels, serum i-PTH levels, serum ALP levels, vitamin D use and calcimimetics use.